• Login
0 Items
Cannin - Cannabis & Hemp Investment Group
  • Home
  • Get Free Trial
  • Cannabis & Hemp News
  • Investment Resources
    • Featured Companies
    • Company Reports
    • Stock Quotes
    • Directory
  • Contact Us
  • Login
Select Page
Is Claritas Pharmaceuticals a Good Investment?

Is Claritas Pharmaceuticals a Good Investment?

Cannabis in the News, CBD Stocks, Finance, Investment Opportunities, marijuana stock, Science, Stock Talk

We continue to see plenty of chatter on social media about Claritas Pharmaceuticals so we figured we would go ahead and do a deep dive fundamental analysis on the company. But is Claritas Pharmaceuticals a good investment? Let’s take a closer look at the...
5 Essentials For Successful Commercial Cannabis Cultivation

5 Essentials For Successful Commercial Cannabis Cultivation

Cannabis in the News, Cannabis Market, Science

Growing cannabis at home is an exciting prospect as you learn about the plant, strains, growing techniques, and more. If you are an avid grower, you may consider graduating to commercial cultivation at some point. But it is a completely different ball game as the...
Psychedelics Renaissance Underway as Paradigm Shifting Cure for Depression Potentially Discovered

Psychedelics Renaissance Underway as Paradigm Shifting Cure for Depression Potentially Discovered

Cannabis in the News, Psychedelic Stocks, Research, Science, Stock Talk, Trending

Psychedelics Renaissance Underway as Paradigm Shifting Cure for Depression Potentially Discovered — VANCOUVER, BC, Sept. 28, 2021 /PRNewswire/ — New clinical trials based out of Australia are exploring the therapeutic benefits of psychedelics (which are...
Revive Therapeutics Provides Update on Psychedelics Clinical Product Pipeline

Revive Therapeutics Provides Update on Psychedelics Clinical Product Pipeline

Cannabis in the News, CBD Stocks, Health, Investment Opportunities, Psychedelic Stocks, Research, Science, Technology/Innovations

Focusing on novel uses, production and delivery forms of psilocybin as a next generation solution for mental illness, substance abuse and neurological disorders Advancing to FDA clinical studies for methamphetamine use disorder and stroke Revive Therapeutics Provides...
Nootropic Mushrooms for Wellness Are on the Rise

Nootropic Mushrooms for Wellness Are on the Rise

Cannabis in the News, Investment Opportunities, Psychedelic Stocks, Research, Science, Wellness

Nootropic Mushrooms for Wellness Are on the Rise and Privy Peach founder launches a new mushroom brand. DENVER, July 29, 2021 /PRNewswire/ — Kim Koehler, Privy Peach CBD brand founder, was recently listed as a Forbes top entrepreneurs to watch, and with good...
Innocan Pharma Announces Filing of a Patent Application for Hair Loss Prevention

Innocan Pharma Announces Filing of a Patent Application for Hair Loss Prevention

Cannabis in the News, CBD in the News, CBD Stocks, Research, Science, Technology/Innovations

Innocan Pharma Announces Filing of a Patent Application for Hair Loss Prevention — Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – July 28, 2021) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the...
« Older Entries

Already Registered,
Login below to add a listing

Login

 
 
Forgot Password

Search Cannabis and Hemp Stocks

Free Cannabis News & Investment Tips

Delivered to your inbox, Every Sunday

Recent Posts

  • Cannin’s Top 5 Cannabis Stocks to Watch Now October 19, 2021
  • Urban-Gro: Is this Cannabis Stock a Strong Buy? October 19, 2021
  • 3 Reasons Why IIPR Will Outperform Marijuana Stocks in 2021 October 19, 2021
  • 3 Volatile Large-Cap Hemp Stocks to Watch for 2021 October 18, 2021
  • 22nd Century: Is this Cannabis Stock a Buy and Hold? October 18, 2021
Top Hemp Stocks to Buy

Cannabis Stock Watchlist

×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
Symbol Last Price % Change

Search for Specific Hemp and Cannabis Stocks

From the Cannin Community

"Cannin sends specific instructions on how to make the trade. They continue to send profitable signals and I love their service. Thanks, Cannin!"

-Mark H.
Vail, Colorado

https://aphrihelios.com/

CanninPlus with Trading Alerts!

Get advance notice of profitable cannabis & hemp stock trades. Use our machine learning algorithm to start profiting from this explosive industry.

GET A FREE TRIAL

$99 / month after 7-day trial. Still unsure? Schedule demo at demo@cannin.com or call 720-254-1374

The Best Cannabis Stocks for 2021

  • Cannin Report Q1 2021 Cannin Report Q2 2021 $99.00 $49.00
  • Cannin Report Q1 2021 Cannin Report Q1 2021 $49.00 $29.00
  • Cannin Ad The Cannin Report 2020 $49.00 $19.00
  • Cannin Ad FREE Sample Cannin Report Q1 2020 - Our #1 Stock Pick $9.99 $0.00
  • Cannin Ad The Cannin Report Q4 2019 $99.00 $29.00

Free Cannabis News & Investment Tips

Delivered to your inbox, Every Sunday

Risk of Prosecution for Marijuana-Related Companies.  If you are considering investing in a company that is connected to the marijuana industry, be aware that marijuana-related companies may be at risk of federal, and perhaps state, criminal prosecution.  The Department of Treasury recently issued guidance noting: “ The Controlled Substances Act (“CSA”) makes it illegal under federal law to manufacture, distribute, or dispense marijuana.  Many states impose and enforce similar prohibitions.  Notwithstanding the federal ban, as of the date of this guidance, 20 states and the District of Columbia have legalized certain marijuana-related activity.”

  • Facebook
  • Twitter
  • Instagram
© 2020 Cannin All Rights Reserved. | Refund | Terms | Privacy | Cannin.com 3000 Lawrence Street #6 Denver, Colorado 80205
CanninBot - Daily Trading Alerts
Terms:
First Week Free, then $39/month. Cancel Anytime.
Invalid Username
Invalid Email
Invalid Password
Password Confirmation Doesn't Match
Have a coupon?
Loading... Invalid Coupon
Authorize.net
Invalid Credit Card Number
Invalid Expiration
Invalid CVC Code
 
Loading... Please fix the errors above
CanninPlus
Terms:
First Week FREE then $99/month. Cancel Anytime.
Invalid Username
Invalid Email
Invalid Password
Password Confirmation Doesn't Match
Have a coupon?
Loading... Invalid Coupon
Authorize.net
Invalid Credit Card Number
Invalid Expiration
Invalid CVC Code
 
Loading... Please fix the errors above